本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再生元制药公司

704.31
+10.811.56%
盘后705.000.6900+0.10%19:59 EST
成交量:113.31万
成交额:7.99亿
市值:740.23亿
市盈率:16.93
高:711.88
开:693.34
低:692.29
收:693.50
52周最高:800.99
52周最低:476.49
股本:1.05亿
流通股本:1.03亿
量比:1.04
换手率:1.10%
股息:2.64
股息率:0.37%
每股收益(TTM):41.59
每股收益(LYR):40.90
净资产收益率:15.19%
总资产收益率:6.16%
市净率:2.39
市盈率(LYR):17.22

数据加载中...

2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/02

SEC问询函

Form CORRESP - Correspondence
2024/08/01

重要事件披露

Form 8-K - Current report
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/08

重要事件披露

Form 8-K - Current report
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities